This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Dave Reichert
Advertisement
Dave Reichert is a technical marketing writer at Precision Nanosystems.
Articles by Dave Reichert
Advertisement
Latest Updated Articles
Accelerating Genetic Medicine R&D Using MicrofluidicsSeptember 15th 2017
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
4
Ionis Reports 2-Year Donidalorsen (Dawnzera) Data in HAE Prophylaxis
5